Concepedia

Zi-Yang Peng

ZP

Statistics

Publications

10

Citations

436

H-Index

10

Active since

2020

Affiliations

First Affiliated Hospital of Xi'an Jiaotong University(Current)

University of Mississippi Medical Center

Thomas Jefferson University

First Affiliated Hospital of Zhengzhou University

Sidney Kimmel Cancer Center

Zi-Yang Peng is an author at First Affiliated Hospital of Xi'an Jiaotong University specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2020–2024

10

Publications

10

M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way

Kai Li, Zi-Yang Peng, Shan Gao et al. · Journal of Experimental & Clinical Cancer Research · 2021 · 94 citations · Full text

, , +17

Enhancement of TKI sensitivity in lung adenocarcinoma through m6A-dependent translational repression of Wnt signaling by circ-FBXW7

Kai Li, Zi-Yang Peng, Rui Wang et al. · Molecular Cancer · 2023 · 88 citations · Full text

, , +17

Stem signatures associated antibodies yield early diagnosis and precise prognosis predication of patients with non-small cell lung cancer

Sisi Chen, Kai Li, Jie Wu et al. · Journal of Cancer Research and Clinical Oncology · 2020 · 56 citations · Full text

, , +14

Stimulation of Let-7 Maturation by Metformin Improved the Response to Tyrosine Kinase Inhibitor Therapy in an m6A Dependent Manner

Kai Li, Shan Gao, Lei Ma et al. · Frontiers in Oncology · 2022 · 52 citations · Full text

, , +17

Stem signatures associating SOX2 antibody helps to define diagnosis and prognosis prediction with esophageal cancer

Zi-Yang Peng, Qing-Shi Wang, Kai Li et al. · Annals of Medicine · 2022 · 42 citations · Full text

, , +17

1–5 of 10